Sagent Pharmaceuticals, Inc. (SGNT) Posts Q2 GAAP EPS of 46c
Tweet Send to a Friend
Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) reported Q2 EPS of $0.46 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
